Preclinical and phase I clinical studies of KW-2450, a dual IGF-1R/IR tyrosine kinase inhibitor, in combination with lapatinib and letrozole

por Umehara, Hiroshi, Maekawa, Yoshimi, Koizumi, Fumito, Shimizu, Makiko, Ota, Toshio, Fouad, Tamer M., Willey, Jie, Kaito, Hidekuni, Shiraishi, Norihiko, Nakashima, Daisuke, Akinaga, Shiro, Ueno, Naoto T.
Publicado 2018

Phenotypic Plasticity in Circulating Tumor Cells Is Associated with Poor Response to Therapy in Metastatic Breast Cancer Patients

por Cohen, Evan N., Jayachandran, Gitanjali, Gao, Hui, Peabody, Phillip, McBride, Heather B., Alvarez, Franklin D., Kai, Megumi, Song, Juhee, Shen, Yu, Willey, Jie S., Lim, Bora, Valero, Vicente, Ueno, Naoto T., Reuben, James M.
Publicado 2023

Distinct epidemiological profiles associated with inflammatory breast cancer (IBC): A comprehensive analysis of the IBC registry at The University of Texas MD Anderson Cancer Cente...

por Fouad, Tamer M., Ueno, Naoto T., Yu, Robert K., Ensor, Joe E., Alvarez, Ricardo H., Krishnamurthy, Savitri, Lucci, Anthony, Reuben, James M., Yang, Wei, Willey, Jie S., Valero, Vicente, Bondy, Melissa L., Cristofinalli, Massimo, Shete, Sanjay, Woodward, Wendy A., El-Zein, Randa
Publicado 2018

A phase Ib study of entinostat plus lapatinib with or without trastuzumab in patients with HER2-positive metastatic breast cancer that progressed during trastuzumab treatment

por Lim, Bora, Murthy, Rashmi K., Lee, Jangsoon, Jackson, Summer A., Iwase, Toshiaki, Davis, Darren W., Willey, Jie S., Wu, Jimin, Shen, Yu, Tripathy, Debu, Alvarez, Ricardo, Ibrahim, Nuhad K., Brewster, Abenaa M., Barcenas, Carlos H., Brown, Powel H., Giordano, Sharon H., Moulder, Stacy L., Booser, Daniel J., Moscow, Jeffrey A., Piekarz, Richard, Valero, Vicente, Ueno, Naoto T.
Publicado 2019